ES2172697T3 - Metodo y composiciones para la sintesis de nucleosidos de dioxolano que tienen una configuracion beta. - Google Patents

Metodo y composiciones para la sintesis de nucleosidos de dioxolano que tienen una configuracion beta.

Info

Publication number
ES2172697T3
ES2172697T3 ES96941539T ES96941539T ES2172697T3 ES 2172697 T3 ES2172697 T3 ES 2172697T3 ES 96941539 T ES96941539 T ES 96941539T ES 96941539 T ES96941539 T ES 96941539T ES 2172697 T3 ES2172697 T3 ES 2172697T3
Authority
ES
Spain
Prior art keywords
compositions
synthesis
nucleosids
dioxolan
beta configuration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96941539T
Other languages
English (en)
Spanish (es)
Inventor
Tarek Mansour
Alex Cimpoia
Krzystof Bednarski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shire Canada Inc
Original Assignee
Shire BioChem Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire BioChem Inc filed Critical Shire BioChem Inc
Application granted granted Critical
Publication of ES2172697T3 publication Critical patent/ES2172697T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES96941539T 1995-12-14 1996-12-13 Metodo y composiciones para la sintesis de nucleosidos de dioxolano que tienen una configuracion beta. Expired - Lifetime ES2172697T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9525606.1A GB9525606D0 (en) 1995-12-14 1995-12-14 Method and compositions for the synthesis of dioxolane nucleosides with › - configuration

Publications (1)

Publication Number Publication Date
ES2172697T3 true ES2172697T3 (es) 2002-10-01

Family

ID=10785435

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96941539T Expired - Lifetime ES2172697T3 (es) 1995-12-14 1996-12-13 Metodo y composiciones para la sintesis de nucleosidos de dioxolano que tienen una configuracion beta.

Country Status (27)

Country Link
US (4) US5922867A (enEXAMPLES)
EP (1) EP0970074B1 (enEXAMPLES)
JP (1) JP3229990B2 (enEXAMPLES)
KR (1) KR100406159B1 (enEXAMPLES)
CN (1) CN1080263C (enEXAMPLES)
AP (1) AP879A (enEXAMPLES)
AT (1) ATE214699T1 (enEXAMPLES)
AU (1) AU706328B2 (enEXAMPLES)
BR (1) BR9612351A (enEXAMPLES)
CA (1) CA2237730C (enEXAMPLES)
DE (1) DE69620042T2 (enEXAMPLES)
DK (1) DK0970074T3 (enEXAMPLES)
EA (1) EA000844B1 (enEXAMPLES)
ES (1) ES2172697T3 (enEXAMPLES)
GB (1) GB9525606D0 (enEXAMPLES)
HU (1) HU224076B1 (enEXAMPLES)
IL (3) IL124663A (enEXAMPLES)
IN (1) IN187349B (enEXAMPLES)
MX (1) MX9804701A (enEXAMPLES)
NO (1) NO309901B1 (enEXAMPLES)
NZ (1) NZ323855A (enEXAMPLES)
OA (1) OA11094A (enEXAMPLES)
PL (1) PL188447B1 (enEXAMPLES)
PT (1) PT970074E (enEXAMPLES)
TW (1) TW341574B (enEXAMPLES)
WO (1) WO1997021706A1 (enEXAMPLES)
ZA (1) ZA9610544B (enEXAMPLES)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410546B1 (en) 1997-04-07 2002-06-25 Triangle Pharmaceuticals, Inc. Use of MKC-442 in combination with other antiviral agents
DE69921829T2 (de) 1998-08-12 2005-10-27 Gilead Sciences, Inc., Foster City Verfahren zur herstellung von 1,3-oxathiolannukleoside
US6979561B1 (en) * 1998-10-09 2005-12-27 Gilead Sciences, Inc. Non-homogeneous systems for the resolution of enantiomeric mixtures
JP2002533470A (ja) 1998-12-23 2002-10-08 シャイアー・バイオケム・インコーポレイテッド 抗ウイルス性ヌクレオシド類似体
CA2362570A1 (en) * 1999-02-11 2000-08-17 Shire Biochem Inc. Stereoselective synthesis of nucleoside analogues
EP1214074B1 (en) * 1999-09-24 2004-06-16 Shire Biochem Inc. Dioxolane nucleoside analogs for the treatment or prevention of viral infection
CA2389745C (en) 1999-11-04 2010-03-23 Shire Biochem Inc. Method for the treatment or prevention of flaviviridae viral infection using nucleoside analogues
US7038039B2 (en) * 2000-02-10 2006-05-02 Mitsui Chemicals, Inc. Process for selectively producing 1-phosphorylated sugar derivative anomer and process for producing nucleoside
WO2001058894A1 (en) * 2000-02-11 2001-08-16 Shire Biochem Inc. Stereoselective synthesis of nucleoside analogues
WO2002051852A1 (fr) * 2000-12-27 2002-07-04 Mitsui Chemicals, Inc. Procede de production d'un derive de saccharide non naturel
WO2002070518A1 (en) * 2001-03-01 2002-09-12 Triangle Pharmaceuticals, Inc. Polymorphic and other crystalline forms of cis-ftc
AU2002329970A1 (en) * 2001-09-04 2003-03-18 Isis Pharmaceuticals, Inc. Pyrrolo(2,3-d)pyrimidines for inhibiting rna-dependent rna viral polymerase
AU2002336864B2 (en) * 2001-11-02 2006-08-17 Shire Biochem Inc. Pharmaceutical compositions for the treatment of leukemia comprising dioxolane nucleosides analogs
US7105527B2 (en) * 2001-12-14 2006-09-12 Otto Michael J N4-acylcytosine nucleosides for treatment of viral infections
JP4441265B2 (ja) * 2002-01-25 2010-03-31 シャー バイオケム インコーポレイティッド ジオキソランヌクレオシド類似体の製造方法
AU2003294212B2 (en) 2002-08-06 2010-01-07 Pharmasset Inc. Processes for preparing 1,3-dioxolane nucleosides
CN101724110B (zh) 2002-10-15 2013-03-27 埃克森美孚化学专利公司 用于烯烃聚合的多催化剂体系和由其生产的聚合物
DE10335061B4 (de) 2003-07-31 2005-11-17 Wacker-Chemie Gmbh Verfahren zur Herstellung von OH-geschützten [4-(2,6-damino-9H-purin-9-yl)-1,3-dioxolan-2-yl]methanol-Derivaten
KR101157468B1 (ko) * 2004-02-03 2012-07-06 에모리 유니버시티 1,3-디옥솔란 뉴클레오시드 제조방법
US7749531B2 (en) * 2005-06-08 2010-07-06 Indicator Systems International Apparatus and method for detecting bacterial growth beneath a wound dressing
BRPI0813036A2 (pt) * 2007-07-30 2017-10-24 Rfs Pharma Llc processo estereosseletivo para preparar derivados do nucleosídeo dioxolana de purina.
CN101862676B (zh) * 2009-04-17 2012-01-25 中国石油化工股份有限公司 大孔径sba-15介孔材料-三氟甲磺酸铜复合催化剂、制备方法及应用
CN103288806A (zh) * 2013-07-02 2013-09-11 山东大学 一种曲沙他滨的合成方法
WO2018022263A1 (en) 2016-07-29 2018-02-01 Exxonmobil Chemical Patents Inc. Polymerization processes using high molecular weight polyhydric quenching agents
WO2019245444A1 (en) 2018-06-21 2019-12-26 Medivir Ab Base-modified cytidine nucleotides for leukemia therapy
JP7337539B2 (ja) * 2018-06-21 2023-09-04 メディヴィル・アクチエボラーグ 白血病療法のための塩基修飾シチジンヌクレオチド

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5276151A (en) * 1990-02-01 1994-01-04 Emory University Method of synthesis of 1,3-dioxolane nucleosides
CN1086519A (zh) * 1992-06-22 1994-05-11 伊莱利利公司 立体有择阴离子糖基化方法

Also Published As

Publication number Publication date
US20030060476A1 (en) 2003-03-27
NO982716D0 (no) 1998-06-12
EP0970074A1 (en) 2000-01-12
PL327443A1 (en) 1998-12-07
BR9612351A (pt) 1999-07-13
IL144155A0 (en) 2002-05-23
EP0970074B1 (en) 2002-03-20
EA199800555A1 (ru) 1999-02-25
DK0970074T3 (da) 2002-07-15
PL188447B1 (pl) 2005-02-28
US5922867A (en) 1999-07-13
KR100406159B1 (ko) 2004-11-16
IN187349B (enEXAMPLES) 2002-03-30
EA000844B1 (ru) 2000-06-26
TW341574B (en) 1998-10-01
GB9525606D0 (en) 1996-02-14
WO1997021706A1 (en) 1997-06-19
PT970074E (pt) 2002-09-30
CN1208414A (zh) 1999-02-17
US6069250A (en) 2000-05-30
IL124663A0 (en) 1998-12-06
CA2237730A1 (en) 1997-06-19
JP2000501714A (ja) 2000-02-15
HK1017886A1 (en) 1999-12-03
US20020058670A1 (en) 2002-05-16
DE69620042T2 (de) 2002-10-17
CA2237730C (en) 2001-12-04
CN1080263C (zh) 2002-03-06
AU706328B2 (en) 1999-06-17
ATE214699T1 (de) 2002-04-15
AP9801252A0 (en) 1998-06-30
DE69620042D1 (de) 2002-04-25
IL144155A (en) 2003-07-06
NO309901B1 (no) 2001-04-17
HUP9901050A2 (hu) 2001-04-28
AP879A (en) 2000-10-02
HUP9901050A3 (en) 2001-05-28
HU224076B1 (hu) 2005-05-30
OA11094A (en) 2003-03-13
JP3229990B2 (ja) 2001-11-19
NZ323855A (en) 1999-11-29
NO982716L (no) 1998-06-12
IL124663A (en) 2001-10-31
ZA9610544B (en) 1997-07-29
AU1089397A (en) 1997-07-03
KR19990072141A (ko) 1999-09-27
MX9804701A (es) 1998-10-31

Similar Documents

Publication Publication Date Title
ES2172697T3 (es) Metodo y composiciones para la sintesis de nucleosidos de dioxolano que tienen una configuracion beta.
KR890003790A (ko) 에피포도필로톡신 배당체의 4'-포스페이트 유도체
DK0474672T3 (da) Hidtil ukendt forbindelsesklasse med et variabelt aktivitetsspektrum af capsaicinlignende responser, præparater og anvendelser deraf
ES2059377T3 (es) Pirazoles 1,5-diaril-3-sustituidos farmacologicamente activos y procedimiento para sintetizar los mismos.
PT96857A (pt) Processo para a preparacao de oxetanonas
BG96717A (bg) Метод и състави за получаване на всн-189 и аналозите му
ATE368660T1 (de) Verfahren zur herstellung von enantiomerisch reine beta-d-dioxolan-nukleoside
DK0594291T3 (da) Fremgangsmåder til fremstilling af 13-etherderivater af milbemyciner og mellemprodukter dertil
BR8800580A (pt) Dionas ciclicas,processo para preparacao de compostos,composicoes e processo para controlar ervas daninhas
AR005790A1 (es) Proceso para la preparar proantocianidinas
FI875279A0 (fi) Synergistisiä kasvin kasvunsäädeseoksia
DE69938306D1 (de) Pflanzen, samen und öle mit erhöhtem gesamtgehalt an einfachgesättigten fettsäuren
MA22932A1 (fr) Procede de preparation de compositions detergentes de densite apparente elevee et composition obtenue par ce procede.
AR248011A1 (es) Procedimiento para la fabricacion de un derivado de diamidin-difenil-alquileno.
BR9302029A (pt) Metodo para produzir uma composicao,metodo para produzir uma solucao aquosa,composicao,e,processo para retardar o crescimento microbial
FI943366L (fi) Menetelmä kasvien käsittelemiseksi siementen laatuominaisuuksien parantamiseksi
DE3585109D1 (de) Verfahren zur herstellung von (+/-)-3a,6,6,9a-tetramethylperhydronaphtho(2,1-b)furan.
ES2037763T3 (es) Metodo para preparar compuestos no naturales afines a la ceramida.
DK461887D0 (da) Fremgangsmaade til selektivt at foroege andelen af enkelte hovedkomponenter af antibiotikum a 40926-kompleks
MX9200487A (es) Metodo para mejorar las caracteristicas de suelos portadores de sulfato.
FR2666095B1 (fr) Production de la l-lysine par fermentation.
DE69232259D1 (de) Verfahren zur Herstellung von Interleukin-6 Zusammensetzungen
ES2106800T3 (es) Composicion que contiene gamma octalactona, procedimiento de fermentacion para su produccion y usos organolepticos de la misma.
DE3582371D1 (de) Oxindolverbindungen, diese enthaltende zusammensetzungen sowie verfahren zur herstellung derselben.
ATE124947T1 (de) Verfahren zur herstellung substituierter cyclobutane.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 970074

Country of ref document: ES